GlassScriptPhysician profile
Kashif Hussain
NPI 1154462513
$2,246.04
in general payments reported to CMS, 2019-2025
20 companies · $661 in 2025
The $661 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $317 · 2021: $121 · 2022: $250 · 2023: $433 · 2024: $465 · 2025: $661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,558.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $679.22 | 2019-2025 | Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $373.66 | 2019-2025 | Airsupra, Breztri, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $292.18 | 2019-2025 | Ofev, Jascayd |
| Electromed, INC. | $132.49 | 2023-2025 | Smartvest |
| Verona Pharma, INC. | $98.99 | 2025 | Ohtuvayre |
| Regeneron Healthcare Solutions, INC. | $97.82 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $90.14 | 2022-2025 | Prolastin-C Liquid |
| Genzyme Corporation | $84.78 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $81.66 | 2019-2025 | Capvaxive |
| Amgen INC. | $49.20 | 2021-2025 | Tezspire |
| Genentech USA, INC. | $39.95 | 2019 | |
| Insmed, INC. | $36.21 | 2025 | Arikayce |
| Baxter Healthcare | $31.59 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Viatris Specialty LLC | $29.39 | 2025 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $28.97 | 2024 | Opsumit |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $23.21 | 2019 | |
| Advanced Respiratory, INC | $22.00 | 2019 | |
| Abbvie INC. | $21.11 | 2023 | |
| Novo Nordisk INC | $19.62 | 2019 | |
| Allergan, INC. | $13.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kashif Hussain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.